New frameshift mutation found in PKP2 gene in arhythmogenic right ventricular cardiomyopathy/dysplasia: a family case study

Mikhail A. Fedyakov; Olga E. Veleslavova; Olga V. Romanova; Yuriy V. Shubik; Stanislav P. Urazov; Sergey D. Rud; Andrey M. Sarana; Sergey G. Scherbak; Oleg S. Glotov

doi:10.21638/11701/spbu10.2019.101

Авторы

Mikhail A. Fedyakov St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation
Olga E. Veleslavova St. Saint-Petersburg State University, University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Olga V. Romanova St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation
Yuriy V. Shubik St. Saint-Petersburg State University, University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Stanislav P. Urazov St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation
Sergey D. Rud S. M. Kirov Military Medical Academy, 6, ul. Academika Lebedeva, St. Petersburg, 194044, Russian Federation
Andrey M. Sarana St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation;St. Saint-Petersburg State University, University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Sergey G. Scherbak St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation ; St. Saint-Petersburg State University, University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Oleg S. Glotov St. Petersburg State Health Care Facility “City Hospital no. 40”, 9, ul. Borisova, St. Petersburg, Sestroretsk, 197706, Russian Federation ; St. Saint-Petersburg State University, University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation;Laboratory of Prenatal Diagnosis, FSBSI “The Research Institute of Obstetrics, Gynecology and Reproductology named after D. O. Ott”, 3, Mendeleevskaya liniya, 3, St. Petersburg, 199034, Russian Federation

DOI:

https://doi.org/10.21638/11701/spbu10.2019.101

Аннотация

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC) is a progressive myocardial disease that primarily affects the right ventricle. It develops predominantly at young age, and the first symptom is often sudden cardiac death (SCD) associated with malignant ventricular arrhythmia. Diagnosis using standard cardiac assessment may be hampered due to slight and nonspecific clinical signs at early stage of the disease, particularly in relatives of the patient. Molecular genetic testing can provide more information for clinical decision making. Here we report a patient with a clinical diagnosis of ARVC who was found to have a new frame shift mutation in the PKP2 gene through molecular genetic testing using Next Generation Sequencing methods. Subsequent family assessment showed that all three of the proband’s children also carried this mutation. The results of molecular diagnostics allowed us to assess the risk of developing ARVC and SCD in relatives of the proband, as well as to set up individual cardiac assessment protocols. Results obtained emphasize the importance of family screening when a pathogenic mutation is detected in the primary patient, and demonstrate the efficiency of genetic testing in cardiological practice.

Ключевые слова:

arrhythmogenic right ventricular cardiomyopathy/dysplasia, sudden cardiac death, Next Generation Sequencing, new frame shift mutation, PKP2 gene, Russian family

Скачивания

Данные скачивания пока недоступны.

Библиографические ссылки

References

Basso C., Corrado D., Marcus F. I., Nava A., Thiene G. Arrhythmogenic right ventricular cardiomyopathy. Lancet, 2009, vol. 373, iss. 9671, pp. 1289–1300.

Sen-Chowdhry S., Syrris P., Prasad S. K., Hughes S. E., Merrifield R., Ward D., Pennell D. J.,McKenna W. J. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J. Am. CollCardiol.,2008, vol. 52, iss. 25, pp. 2175–2187.

Peters S., Trümmel M., Meyners W. Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital. Int. J. Cardiol., 2004, vol. 97, iss. 3, pp. 499–501.

Nava A., Bauce B., Basso C., Muriago M., Rampazzo A., Villanova C. et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J. Am. CollCardiol., 2000, vol. 36, iss. 7, pp. 2226–2233.

Thiene G., Nava A., Corrado D., Rossi L., Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med., 1988, vol. 318, pp. 129–133.

Marcus F. I., McKenna W. J., Sherrill D., Basso C., Bauce B., Bluemke D. A., Calkins H., Corrado D., Cox M. G. P. J., Daubert J. P., Fontaine G., Gear K., Auer H., Nava R., Picard A., Protonotarios M. H.,Safitz N., Yoeger J. E., Sanborn D. M., Steinberg J. S., Tandri H., Theine G., Towbin J. A., Tsatsopoulou A.,Wichter T., Zareba W. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia:proposed modification of the task force criteria.Circulation, 2010, vol. 121, pp. 1533–1541.

Lazzarini E., Jongbloed J. D., Pilichou K. et al. The ARVD/C Genetic Variants Database: 2014 Update. Hum. Mutat., 2015, vol. 6, iss. 4, pp. 403–410.

Van der Zwaag P. A., van Rijsingen I. A., Asimaki A., Jongbloed J. D., van Veldhuisen D. J., Wiesfeld A. C.et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur. J. Heart. Fail., 2012, vol. 14, iss. 11, pp. 1199–1207.

Van Tintelen J. P., Entius M. M., Bhuiyan Z. A., Jongbloed R., Wiesfeld A. C., Wilde A. A. et al.Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation, 2006, vol. 113, iss. 13, pp. 1650–1658.

Kapplinger J. D., Landstrom A. P., Salisbury B. A., Callis T. E., Pollevick G. D., Tester D. J. et al.Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J. Am. CollCardiol., 2011, vol. 57, iss. 23, pp. 2317–2327.

Ackerman M. J., Priori S. G., Willems S., Berul C., Brugada R., Calkins H. et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies:this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).Europace, 2011, vol. 13, iss. 8, pp. 1077–1109.

Sambrook J., Fritsch E. P., Maniatis T. Molecular cloning: a laboratory. Cold Spring Harbor. New York,1989.

Rehm H. L., Bale S. J., Bayrak-Toydemir P., Berg J. S., Brown K. K., Deignan J. L., Friez M. J., Funke B. H.,Hegde M. R., Lyon E. ACMG clinical laboratory standards for next-generation sequencing. Genet.Med., 2013, vol. 15, iss. 9, pp. 733–747.

Groeneweg J. A., Bhonsale A., James C. A. Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members. Circ. Cardiovasc. Genet., 2015, vol. 8, iss. 3, pp. 437–446.

Glotov A. S., Kazakov S. V., Zhukova E. A. et al. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group. Clinica Chimica Acta, 2015, vol. 446, pp. 132–140.

Kostareva A., Gudkova A., Sjoberg G., Kiselev I., Moiseeva O., Karelkina E., Goldfarb L., Schlyakhto E.,Sejersen T. Desmin mutations in a St. Petersburg cohort of cardiomyopathies. Acta Myol., 2006, vol. 25,pp. 109–115.

Kostareva A., Sjoberg G., Gudkova A., Smolina N., Semernin E., Shlyakhto E., Sejersen T., Desmin A.Desmin 213V substitution represents a rare polymorphism but not a mutation and is more prevalent in patients with heart dilation of various origins. Acta Myol., 2011, vol. 30, pp. 42–45.

Fedyakov M. A., Veleslavova O. E., Glotov O. S. et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical and molecular features. Vestnik aritmologii, 2015, vol. 81, pp. 33–41. (In Russian)

Huber O. Structure and function of desmosomal proteins and their role in development and disease. Cell. Mol. Life Sci., 2003, vol. 60, iss. 9, pp. 1872–1890.

Churilov L. P. On the Systemic Approach in General Pathology: the Necessity and Principles of Pathoinformatics. Vestnik of Saint Petersburg University. Meditsina, 2009, vol. 3, pp. 3–23. (In Russian)

Veleslavova O. E., Gordeeva M. V., Zheleznyak I. S. et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia, a review. Proceeding I. Vestnik of Saint Petersburg University. Meditsina, 2014, vol. 1, pp. 26–42. (In Russian)

Gordeeva M. V., Mitrofanova L. B., Veleslavova O. E., Zheleznyak I. S. et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia, a review. Proceeding II. Vestnik of Saint Petersburg University.Meditsina, 2014, vol. 1, pp. 43–54.